ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

DAVIDSON KEMPNER CAPITAL MANAGEMENT LP's Holding History (CIK: 0001595082)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 65,000,000 Value ($000) $84,435 Avg Close — Range —
Q1 2025
Shares 50,000,000 Value ($000) $57,575 Avg Close — Range —
Q4 2024
Shares 55,000,000 Value ($000) $58,463 Avg Close — Range —
Q3 2024
Shares 45,000,000 Value ($000) $52,605 Avg Close — Range —
Q2 2024
Shares 52,500,000 Value ($000) $56,569 Avg Close — Range —
Q1 2024
Shares 30,000,000 Value ($000) $28,196 Avg Close — Range —
Q4 2023
Shares 35,000,000 Value ($000) $34,388 Avg Close — Range —
Q3 2023
Shares 30,000,000 Value ($000) $27,675 Avg Close — Range —